Treatment of cancer patients often fails because of the resistance in the tumor to chemotherapeutic drugs. A better understanding of mechanisms which are active in resistant cells might lead to measures to circumvent the resistance. This review deals with the mechanisms of action of cisplatin (CDDP) and the various causes for CDDP resistance in the tumor cells. Also, possibilities to circumvent CDDP resistancein vitro andin vivo are presented
Bladder cancer is the 9th most common tumour worldwide with Urothelial Carcinoma (UC) being the most...
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumor...
Studies were undertaken to investigate acquired resistance to cisplatin in human ovarian cancer cell...
Treatment of cancer patients often fails because of the resistance in the tumor to chemotherapeutic ...
Cisplatin (CDDP) is an active cytostatic agent. A limitation to its effectiveness initially or appea...
Cisplatin (cis-diamminedichloroplatinum (II)), is a platinum based chemotherapeutic employed in the ...
Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell de...
Adriamycin (Adr) and cisplatin (CDDP) play an important role in cancer chemotherapy. However, the fr...
Cisplatin (CDDP) resistance mechanisms were studied in a model of three germ cell tumour and three c...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
[[abstract]]Although cisplatin has been a pivotal chemotherapy drug in treating patients with variou...
Cisplatin (cis-diamminedichloroplatinum(II)) is one of the most important agents used in clinical on...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
In an attempt to examine the cellular changes associated with cisplatin resistance, we selected a ci...
Lung cancer is one of the most lethal types of cancer due to a lack of proper treatment. The rare pr...
Bladder cancer is the 9th most common tumour worldwide with Urothelial Carcinoma (UC) being the most...
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumor...
Studies were undertaken to investigate acquired resistance to cisplatin in human ovarian cancer cell...
Treatment of cancer patients often fails because of the resistance in the tumor to chemotherapeutic ...
Cisplatin (CDDP) is an active cytostatic agent. A limitation to its effectiveness initially or appea...
Cisplatin (cis-diamminedichloroplatinum (II)), is a platinum based chemotherapeutic employed in the ...
Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell de...
Adriamycin (Adr) and cisplatin (CDDP) play an important role in cancer chemotherapy. However, the fr...
Cisplatin (CDDP) resistance mechanisms were studied in a model of three germ cell tumour and three c...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
[[abstract]]Although cisplatin has been a pivotal chemotherapy drug in treating patients with variou...
Cisplatin (cis-diamminedichloroplatinum(II)) is one of the most important agents used in clinical on...
Many mechanisms of cisplatin resistance have been proposed from studies of cellular models of resist...
In an attempt to examine the cellular changes associated with cisplatin resistance, we selected a ci...
Lung cancer is one of the most lethal types of cancer due to a lack of proper treatment. The rare pr...
Bladder cancer is the 9th most common tumour worldwide with Urothelial Carcinoma (UC) being the most...
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumor...
Studies were undertaken to investigate acquired resistance to cisplatin in human ovarian cancer cell...